HighVista Strategies LLC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1335325 BOSTON, MA

Position in AMLX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,893,981

+$2,009,133 QoQ

Shares Held

352,085

+47.4% QoQ

Ownership

0.317%

of shares outstanding

% of Portfolio

1.36%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

5 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HighVista Strategies LLC holds $12,144,053 across 4 Drug Manufacturers - Specialty & Generic names. AMLX ranks #1 (40.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMLX	Amylyx Pharmaceuticals, Inc. This page	352,085	$4,893,981
2	LQDA	Liquidia Corp	99,744	$3,764,338
3	ALKS	Alkermes plc.	73,189	$2,587,963
4	UTHR	UNITED THERAPEUTICS Corp	1,514	$897,771

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,893,981	352,085	+47.4%	Shares	Sole	2026-05-15
2025-12-31	$2,884,848	238,812	+806.3%	Shares	Sole	2026-02-17
2023-12-31	$387,857	26,349	0.0%	Shares	Sole	2024-02-14
2023-09-30	$482,450	26,349	+91.7%	Shares	Sole	2023-11-14
2023-06-30	$296,544	13,748	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.